San Diego, CA -- (SBWIRE) -- 06/07/2016 -- Certain directors of Intrexon Corp are under investigation over possible wrongdoing. The investigation was announced on behalf of current long-term investors in NYSE:XON shares concerning potential breaches of fiduciary duties by certain directors of Intrexon Corp.

Investors who are current long term investors in Intrexon Corp (NYSE:XON) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

The investigation by a law firm for investors in NYSE:XON stocks follows a lawsuit filed recently against Intrexon Corp over alleged securities laws violations. The investigation on behalf of current long term investors in NYSE:XON stocks, concerns whether certain Intrexon directors are liable in connection with the allegations made in that lawsuit. According to that complaint filed in the U.S. District Court for the Northern District of California the plaintiff alleges that the defendants issued false and misleading financial statements to investors.

On April 21, 2016, a report was published on Intrexon Corp asserting, among other things, that Intrexon's technology has recently been questioned by high-ranking officials from the WHO, CDC and NIH, that Intrexon overstated revenues by 50% through transactions with related parties, thatIntrexon's technology platform is an overhyped, undifferentiated collection of commodity and failed products, and that Intrexon is the Theranos of the public markets.

Shares of Intrexon Corp (NYSE:XON) closed on June 3, 2016 at $28.96 per share.

Those who purchased shares of Intrexon Corp have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com